This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Patrick Joseph Antonellis and Oligonucleotide Delivery Innovation.
Introduction
Patrick Joseph Antonellis is an inventor associated with Indianapolis, Indiana, and Eli Lilly and Company. His patent work concerns delivery technologies for oligonucleotides, molecules with potential applications in treating disease.
Latest Patents
Antonellis is credited with 1 patent: “Therapeutic Delivery Moieties and Uses Thereof.” The invention describes novel compounds containing delivery moieties designed to transport oligonucleotides. The patent identifies treatment of diseases, particularly liver diseases, as a potential use.
Career Highlights
Antonellis’s listed patent reflects research into improving how oligonucleotides are delivered for therapeutic purposes. This work connects molecular delivery approaches with the development of potential treatments for disease.
Collaborations
His listed coworkers include Gregory Lawrence Lackner and Takako Wilson. The patent’s collaborative research is associated with Eli Lilly and Company.
Conclusion
Patrick Joseph Antonellis’s patent focuses on novel delivery moieties for oligonucleotides, highlighting a therapeutic research direction with potential relevance to liver disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile